Peptides and related compounds having thrombopoietic activity
Details for Australian Patent Application No. 2007201923 (hide)
International Classifications
Event Publications
17 May 2007 Complete Application Filed
24 May 2007 Application Open to Public Inspection
Published as AU-A-2007201923
7 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
22 October 2009 Section 223 Application Received
Amgen Inc. An application to extend the time from 11 Apr 2009 to 11 Aug 2009 in which to pay a renewal fee has been filed . Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 2008
10 December 2009 Section 223 Application Allowed
Amgen Inc. The time in which to pay a continuation fee has been extended to 11 Aug 2009. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000
17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser